Medlera Cardiac Troponin I (cTnI) Rapid Test

Medlera Troponin I Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection of Cardiac Tropnin I (cTnI) and its complex in human whole blood, serum or plasma at a level equal to or higher than 0.3 ng/mL. It is intended to be used as a screening test and as an aid in the diagnosis of acute myocardial infarction (AMI).

Category:

Description

01. Accurate Diagnosis:

Ability to accurately diagnose elevated levels of cardiac Troponin I (cTnI), providing critical information for cardiac health assessment.

02. Improved AMI Diagnosis:

Helps in the diagnosis of acute myocardial infarction (AMI), facilitating timely and precise medical intervention.

03. Dual Colour Detection:

World’s first Dual colour detection technology, enhancing detection accuracy and reliability.

04. Easy Interpretation:

Easy interpretation with RED test line, ensuring user-friendly and clear results.

05. Faster Clearance:

Faster and clearer background clearance, streamlining the testing process.

06. Rapid Results:

Interpret results in 20 minutes, providing quick and actionable information.

07. High Sensitivity:

First rapid test with Sensitivity of 0.3 ng/mL, ensuring accurate detection even at low concentrations.

08. High Specificity:

Sensitivity: >99.00%, Specificity: >99.80%, providing reliable and precise results.

09. No Cross Reactivity:

No cross-reactivity with 10 µg/mL skeletal muscle TnI, 2000 ng/mL cardiac muscle TnT, 20 µg/mL cardiac muscle Myosin, 150 IU/L CKMB, 800 ng/mL Myoglobin.

10. No Hook Effect:

No hook effect observed for cTnI at concentrations up to 3500 µg/mL, ensuring accurate and reliable results.

Additional information

What is detected

Troponin-I (cTnI)

Its function

Aid in the diagnosis of myocardial infarction (MI).

The type of specimen required

human whole blood, serum or plasma.

The intended user

Professional Technical Person.

Sensitivity of Test

100%